These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 34823564

  • 1. Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy.
    Xu S, Jiang C, Lin R, Wang X, Hu X, Chen W, Chen X, Chen T.
    J Exp Clin Cancer Res; 2021 Nov 25; 40(1):373. PubMed ID: 34823564
    [Abstract] [Full Text] [Related]

  • 2. Genome-wide CRISPR screen identifies ELP5 as a determinant of gemcitabine sensitivity in gallbladder cancer.
    Xu S, Zhan M, Jiang C, He M, Yang L, Shen H, Huang S, Huang X, Lin R, Shi Y, Liu Q, Chen W, Mohan M, Wang J.
    Nat Commun; 2019 Dec 02; 10(1):5492. PubMed ID: 31792210
    [Abstract] [Full Text] [Related]

  • 3. α-Mangostin suppresses the de novo lipogenesis and enhances the chemotherapeutic response to gemcitabine in gallbladder carcinoma cells via targeting the AMPK/SREBP1 cascades.
    Shi Y, Fan Y, Hu Y, Jing J, Wang C, Wu Y, Geng Q, Dong X, Li E, Dong D.
    J Cell Mol Med; 2020 Jan 02; 24(1):760-771. PubMed ID: 31762191
    [Abstract] [Full Text] [Related]

  • 4. Overexpression of microRNA-205-5p exerts suppressive effects on stem cell drug resistance in gallbladder cancer by down-regulating PRKCE.
    Zhang GF, Wu JC, Wang HY, Jiang WD, Qiu L.
    Biosci Rep; 2020 Sep 30; 40(9):. PubMed ID: 32869841
    [Abstract] [Full Text] [Related]

  • 5. Calreticulin: a potential diagnostic and therapeutic biomarker in gallbladder cancer.
    Ye J, Qi L, Du Z, Yu L, Chen K, Li R, Feng R, Zhai W.
    Aging (Albany NY); 2021 Feb 11; 13(4):5607-5620. PubMed ID: 33591948
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of autophagy by chloroquine enhances the antitumor activity of gemcitabine for gallbladder cancer.
    Wang FT, Wang H, Wang QW, Pan MS, Li XP, Sun W, Fan YZ.
    Cancer Chemother Pharmacol; 2020 Aug 11; 86(2):221-232. PubMed ID: 32654071
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA SSTR5-AS1 facilitates gemcitabine resistance via stabilizing NONO in gallbladder carcinoma.
    Xue Z, Yang B, Xu Q, Zhu X, Qin G.
    Biochem Biophys Res Commun; 2020 Feb 19; 522(4):952-959. PubMed ID: 31810606
    [Abstract] [Full Text] [Related]

  • 8. ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.
    Yang L, Wang H, Guo M, He M, Zhang W, Zhan M, Liu Y.
    Cell Oncol (Dordr); 2023 Aug 19; 46(4):1085-1095. PubMed ID: 36988891
    [Abstract] [Full Text] [Related]

  • 9. Deciphering the role of Enterococcus faecium cytidine deaminase in gemcitabine resistance of gallbladder cancer.
    Jiang L, Zhang L, Shu Y, Zhang Y, Gao L, Qiu S, Zhang W, Dai W, Chen S, Huang Y, Liu Y.
    J Biol Chem; 2024 Apr 19; 300(4):107171. PubMed ID: 38492776
    [Abstract] [Full Text] [Related]

  • 10. Pretreatment with Gemcitabine/5-Fluorouracil Enhances the Cytotoxicity of Trastuzumab to HER2-Negative Human Gallbladder Cancer Cells In Vitro and In Vivo.
    Wang W, Hu Z, Huang Y, Zheng H, Sun Q, Yang Q, Zhang Y, Zhang L, Wang W.
    Biomed Res Int; 2019 Apr 19; 2019():9205851. PubMed ID: 31019975
    [Abstract] [Full Text] [Related]

  • 11. MCL1 participates in leptin-promoted mitochondrial fusion and contributes to drug resistance in gallbladder cancer.
    Wang WJ, Lai HY, Zhang F, Shen WJ, Chu PY, Liang HY, Liu YB, Wang JM.
    JCI Insight; 2021 Aug 09; 6(15):. PubMed ID: 34156978
    [Abstract] [Full Text] [Related]

  • 12. Low expression of equilibrative nucleoside transporter 1 is associated with poor prognosis in chemotherapy-naïve pT2 gallbladder adenocarcinoma patients.
    Espinoza JA, García P, Bizama C, Leal JL, Riquelme I, Weber H, Macanas P, Aguayo G, Viñuela E, Roa JC, Nervi B.
    Histopathology; 2016 Apr 09; 68(5):722-8. PubMed ID: 26266900
    [Abstract] [Full Text] [Related]

  • 13. Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.
    Yang C, Xu M, Shen HJ, Zhu HY, Li F, He M, Chen T, Wang J, Shi WJ, Ji F.
    Int J Clin Exp Pathol; 2014 Apr 09; 7(2):521-8. PubMed ID: 24551272
    [Abstract] [Full Text] [Related]

  • 14. High infiltration of mast cells is associated with improved response to adjuvant chemotherapy in gallbladder cancer.
    Bo X, Wang J, Wang C, Nan L, Gao Z, Xin Y, Li M, Shen S, Liu H, Ni X, Suo T, Zhang D, Lu P, Wang Y, Liu H.
    Cancer Sci; 2020 Mar 09; 111(3):817-825. PubMed ID: 31925976
    [Abstract] [Full Text] [Related]

  • 15. miR-218-5p restores sensitivity to gemcitabine through PRKCE/MDR1 axis in gallbladder cancer.
    Wang H, Zhan M, Xu SW, Chen W, Long MM, Shi YH, Liu Q, Mohan M, Wang J.
    Cell Death Dis; 2017 May 11; 8(5):e2770. PubMed ID: 28492560
    [Abstract] [Full Text] [Related]

  • 16. Maslinic acid potentiates the antitumor activities of gemcitabine in vitro and in vivo by inhibiting NF-κB-mediated survival signaling pathways in human gallbladder cancer cells.
    Yu Y, Wang J, Xia N, Li B, Jiang X.
    Oncol Rep; 2015 Apr 11; 33(4):1683-90. PubMed ID: 25633045
    [Abstract] [Full Text] [Related]

  • 17. DNMT3A Cooperates with YAP/TAZ to Drive Gallbladder Cancer Metastasis.
    Xu S, Yuan Z, Jiang C, Chen W, Li Q, Chen T.
    Adv Sci (Weinh); 2024 Apr 11; 11(16):e2308531. PubMed ID: 38380551
    [Abstract] [Full Text] [Related]

  • 18. Combination chemotherapy of nafamostat mesylate with gemcitabine for gallbladder cancer targeting nuclear factor-κB activation.
    Iwase R, Haruki K, Fujiwara Y, Furukawa K, Shiba H, Uwagawa T, Misawa T, Ohashi T, Yanaga K.
    J Surg Res; 2013 Sep 11; 184(1):605-12. PubMed ID: 23830367
    [Abstract] [Full Text] [Related]

  • 19. Hispidulin inhibits proliferation and enhances chemosensitivity of gallbladder cancer cells by targeting HIF-1α.
    Gao H, Xie J, Peng J, Han Y, Jiang Q, Han M, Wang C.
    Exp Cell Res; 2015 Mar 15; 332(2):236-46. PubMed ID: 25499970
    [Abstract] [Full Text] [Related]

  • 20. Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB.
    Zhang DC, Liu JL, Ding YB, Xia JG, Chen GY.
    Acta Pharmacol Sin; 2013 Feb 15; 34(2):301-8. PubMed ID: 23274410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.